Search

everythinglearnresearchcommunity

for

Search:↓

IL-17 is more important than IFN-γ in causing severe hair loss in chronic alopecia areata.

In 2019, dermatology and venereology improved skin cancer imaging, advanced in treating skin conditions like psoriasis, and explored the skin microbiome's role in diseases.

Ustekinumab significantly improved sexual function and quality of life for people with moderate to severe psoriasis.

Ustekinumab significantly improved psoriasis, vitiligo, and alopecia areata in a patient.

Risankizumab may help manage symptoms of dissecting cellulitis of the scalp.

Bimekizumab effectively treats scalp cellulitis and improves quality of life.

Infliximab was effective in treating a scalp condition that did not respond to other treatments.

Some IBD patients on anti-TNFs developed severe skin issues, but ustekinumab helped.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Etanercept effectively treated a severe skin condition when other treatments failed.

Certolizumab effectively treats psoriasis and psoriatic arthritis with fewer side effects than adalimumab.

Ustekinumab might work for severe psoriasis, but more research is needed to be sure.

Risankizumab effectively treats and maintains skin clearance in moderate-to-severe psoriasis.

Ustekinumab effectively treated psoriasis and ulcerative colitis in a teen after infliximab caused complications.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.

Ixekizumab is effective and safe for patients who did not improve with etanercept treatment for psoriasis.

Adalimumab improved folliculitis decalvans in most patients.

Guselkumab effectively treats skin reactions caused by adalimumab in certain conditions.

Adalimumab effectively stabilized severe folliculitis decalvans, preventing further hair loss and inflammation.

Dupilumab improved severe atopic dermatitis in a patient who didn't respond to other treatments.

Ixekizumab has known and some unexpected side effects.

Bimekizumab can improve scarring alopecia in severe psoriasis.

Bimekizumab quickly improves psoriasis symptoms and skin at the molecular level.

A combination of ixekizumab and tofacitinib successfully treated severe scalp cellulitis, leading to hair regrowth.

Adalimumab significantly improved symptoms and quality of life in two patients with Hidradenitis Suppurativa.

Bimekizumab effectively treated a man's chronic beard hair loss.

Upadacitinib effectively treats psoriasiform eczema and some related conditions.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.